DK1121356T3 - 3-tetrahydropyridin-4-yl-indoler til behandling af psykotiske lidelser - Google Patents

3-tetrahydropyridin-4-yl-indoler til behandling af psykotiske lidelser

Info

Publication number
DK1121356T3
DK1121356T3 DK99952604T DK99952604T DK1121356T3 DK 1121356 T3 DK1121356 T3 DK 1121356T3 DK 99952604 T DK99952604 T DK 99952604T DK 99952604 T DK99952604 T DK 99952604T DK 1121356 T3 DK1121356 T3 DK 1121356T3
Authority
DK
Denmark
Prior art keywords
tetrahydropyridin
indoles
treatment
psychotic disorders
psychotic
Prior art date
Application number
DK99952604T
Other languages
Danish (da)
English (en)
Inventor
Martinus T M Tulp
Der Heijden Johannes A M Van
Vliet Bernard Van
Jacobus Tipker
Hes Roelof Van
Cornelis G Kruse
Gerben M Visser
Original Assignee
Duphar Int Res
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Duphar Int Res filed Critical Duphar Int Res
Application granted granted Critical
Publication of DK1121356T3 publication Critical patent/DK1121356T3/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/18Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/22Anxiolytics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/24Antidepressants

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Neurology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
DK99952604T 1998-10-16 1999-10-15 3-tetrahydropyridin-4-yl-indoler til behandling af psykotiske lidelser DK1121356T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP98203499 1998-10-16
PCT/EP1999/007912 WO2000023441A1 (en) 1998-10-16 1999-10-15 3-tetrahydropyridin-4-yl indoles for treatment of psychotic disorders

Publications (1)

Publication Number Publication Date
DK1121356T3 true DK1121356T3 (da) 2003-03-24

Family

ID=8234230

Family Applications (1)

Application Number Title Priority Date Filing Date
DK99952604T DK1121356T3 (da) 1998-10-16 1999-10-15 3-tetrahydropyridin-4-yl-indoler til behandling af psykotiske lidelser

Country Status (29)

Country Link
US (1) US6391896B1 (sk)
EP (1) EP1121356B1 (sk)
JP (1) JP4659984B2 (sk)
KR (1) KR100619464B1 (sk)
CN (1) CN1140524C (sk)
AR (1) AR020773A1 (sk)
AT (1) ATE230741T1 (sk)
AU (1) AU750811B2 (sk)
BR (1) BR9914582A (sk)
CA (1) CA2346896C (sk)
CZ (1) CZ20011353A3 (sk)
DE (1) DE69904849T2 (sk)
DK (1) DK1121356T3 (sk)
DZ (1) DZ2917A1 (sk)
ES (1) ES2188260T3 (sk)
HK (1) HK1039333A1 (sk)
HU (1) HUP0104701A3 (sk)
IL (2) IL142589A0 (sk)
NO (1) NO320531B1 (sk)
NZ (1) NZ511289A (sk)
PL (1) PL195734B1 (sk)
RU (1) RU2222535C2 (sk)
SI (1) SI1121356T1 (sk)
SK (1) SK285764B6 (sk)
TR (1) TR200101808T2 (sk)
TW (1) TW577884B (sk)
UA (1) UA66888C2 (sk)
WO (1) WO2000023441A1 (sk)
ZA (1) ZA200103251B (sk)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2373855A1 (en) * 1999-05-12 2000-11-23 Solvay Pharmaceuticals B.V. Method of treating psychotic disorders
SK287018B6 (sk) 1999-08-23 2009-09-07 Solvay Pharmaceuticals B. V. Deriváty fenylpiperazínov, spôsob ich prípravy, farmaceutická kompozícia s ich obsahom a ich použitie
AR032711A1 (es) * 2001-02-21 2003-11-19 Solvay Pharm Bv Derivados de fenilpiperazina, un metodo para la preparacion de los mismos y una composicion farmaceutica que los contiene
AR032712A1 (es) * 2001-02-21 2003-11-19 Solvay Pharm Bv Un mesilato de derivados de fenilpiperazina y composiciones farmaceuticas que lo contienen
US7371769B2 (en) 2004-12-07 2008-05-13 Solvay Pharmaceuticals B.V. Tetrahydropyridin-4-yl indoles with a combination of affinity for dopamine-D2 receptors and serotonin reuptake sites
US8101619B2 (en) 2004-12-08 2012-01-24 Solvay Pharmaceuticals B.V. Phenylpiperazine derivatives with a combination of partial dopamine-D2 receptor agonism and serotonin reuptake inhibition
US9709700B2 (en) * 2005-04-06 2017-07-18 3M Innovative Properties Company Optical bodies including rough strippable boundary layers
ATE411161T1 (de) 2005-04-06 2008-10-15 3M Innovative Properties Co Optische körper mit rauen abziehbaren grenzschichten und asymmetrischen oberflächenstrukturen
US20060227421A1 (en) * 2005-04-06 2006-10-12 Stover Carl A Optical bodies including strippable boundary layers

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4414113A1 (de) * 1994-04-22 1995-10-26 Merck Patent Gmbh 3-Indolylpiperidine
US5576321A (en) 1995-01-17 1996-11-19 Eli Lilly And Company Compounds having effects on serotonin-related systems
ZA9711376B (en) 1996-12-20 1998-07-21 Lundbeck & Co As H Indole or dihydroindole derivatives

Also Published As

Publication number Publication date
JP2002527515A (ja) 2002-08-27
HUP0104701A3 (en) 2003-01-28
IL142589A (en) 2007-10-31
NO320531B1 (no) 2005-12-19
KR100619464B1 (ko) 2006-09-05
NO20011892L (no) 2001-06-12
HUP0104701A2 (hu) 2002-04-29
CA2346896A1 (en) 2000-04-27
BR9914582A (pt) 2001-07-03
JP4659984B2 (ja) 2011-03-30
ZA200103251B (en) 2002-07-22
PL347329A1 (en) 2002-03-25
SK5122001A3 (en) 2001-10-08
ES2188260T3 (es) 2003-06-16
IL142589A0 (en) 2002-03-10
SI1121356T1 (en) 2003-04-30
PL195734B1 (pl) 2007-10-31
CA2346896C (en) 2008-12-09
TW577884B (en) 2004-03-01
WO2000023441A1 (en) 2000-04-27
CN1328553A (zh) 2001-12-26
NO20011892D0 (no) 2001-04-17
US6391896B1 (en) 2002-05-21
RU2222535C2 (ru) 2004-01-27
CN1140524C (zh) 2004-03-03
EP1121356B1 (en) 2003-01-08
HK1039333A1 (en) 2002-04-19
AR020773A1 (es) 2002-05-29
AU750811B2 (en) 2002-07-25
DZ2917A1 (fr) 2004-06-20
NZ511289A (en) 2003-01-31
DE69904849T2 (de) 2003-11-13
TR200101808T2 (tr) 2001-10-22
AU6474199A (en) 2000-05-08
KR20010080183A (ko) 2001-08-22
CZ20011353A3 (cs) 2001-09-12
SK285764B6 (sk) 2007-07-06
UA66888C2 (uk) 2004-06-15
EP1121356A1 (en) 2001-08-08
ATE230741T1 (de) 2003-01-15
DE69904849D1 (de) 2003-02-13

Similar Documents

Publication Publication Date Title
DK0967214T3 (da) Intranasale formuleringer til behandling af seksuelle forstyrrelser
DK1147083T3 (da) Arylpiperazinyl-cyclohexylindolderivater til behandling af depression
DK1343773T3 (da) Thiazolderivater til behandling af PPAR-beslægtede forstyrrelser
DK1063990T3 (da) Anvendelse af Biochanin-beriget ekstrakt til behandling af östrogen-associerede lidelser
DK1112106T3 (da) Serotonerge 5HT2-agonister til behandling af glaukom
DK1144395T3 (da) 2-amino-benzoxazinon-derivater til behandling af fedme
DK1231920T3 (da) Anvendelse af epinastin til behandling af allergisk rhinitis/conjunctivitis
DK1165510T3 (da) 1-arensulfonyl-2-aryl-pyrrolidin- og -piperidinderivater til behandling af CNS-lidelser
DK1392318T3 (da) 15-keto-prostaglandiner til behandling af lægemiddelinduceret forstoppelse
DK1206436T3 (da) Retinoider til behandling af emfysem
ID27214A (id) Triazolopiridina untuk pengobatan gangguan trombosis
DK1121356T3 (da) 3-tetrahydropyridin-4-yl-indoler til behandling af psykotiske lidelser
DK1468996T3 (da) Indolderivater til behandling af CNS-sygdomme
DK1268482T3 (da) Pyranoindoler til behandling af glaukom
NO20003481D0 (no) FremgangsmÕte for behandling av COPD
DK1200447T3 (da) Oxazinocarbazoler til behandling af CNS-sygdomme
NO20012612D0 (no) Isonipecotamider for behandling av integren-formidlede lidelser
NO20030127L (no) Indolderivater nyttige for behandling av CNS-forstyrrelser
IS6098A (is) Ósantant til meðhöndlunar á skaptruflunum
DK1468686T3 (da) S-methyl-dihydro-ziprasidon til behandling af psykiatriske lidelser
NO20026029L (no) Indolderivater nyttige for behandlingen av CNS-forstyrrelser
NO982014L (no) Fremgangsmåte for beregning av varighet av oppkoblinger
NO20026028D0 (no) Indolderivater nyttige for behandlingen av CNS-forstyrrelser
NO20005351D0 (no) Paroksetin 10-kamfersulfonat for behandling av CNS lidelser
DK0949237T3 (da) Fremgangsmåde til fremstilling af dihydrocitral